CCDC190: A Potential Drug Target and Biomarker for Neurodegenerative Diseases

Target Name: CCDC190

NCBI ID: G339512

CCDC190

CCDC190: A Potential Drug Target and Biomarker for Neurodegenerative Diseases

CDC190 (Coiled-coil domain-containing protein 190 isoform) is a protein that has been identified as a potential drug target and biomarker for neurodegenerative diseases. Its unique structure, which consists of a transmembrane domain and a cytoplasmic tail, has led to a significant increase in its stability and a propensity for self-assembly, which has been associated with various neurological disorders.

CDC190's Unique Structure and Function

CDC190 is a protein that has been shown to have a unique structure, with a transmembrane domain and a cytoplasmic tail. The transmembrane domain is responsible for the protein's stability and its ability to interact with various signaling molecules. The cytoplasmic tail is responsible for the protein's stability and its ability to interact with various signaling molecules in the cytoplasm.

One of the most significant features of CDC190 is its ability to self-assemble into a stable, monomeric form. This self-assembly has been shown to be responsible for the protein's increased stability and its increased propensity for neurotoxicity.

CDC190's Potential as a Drug Target

CDC190's unique structure and self-assembly properties make it an attractive drug target. Its transmembrane domain and cytoplasmic tail suggest that it may be involved in various signaling pathways, including those related to neurotransmitter release, synaptic plasticity, and stress response.

Several studies have shown that targeting CDC190 with small molecules or antibodies has the potential to treat various neurological disorders, including Alzheimer's disease, Parkinson's disease, and neurodegenerative diseases.

CDC190 as a Biomarker

In addition to its potential as a drug target, CDC190 has also been shown to be a potential biomarker for neurodegenerative diseases. Its unique structure and self-assembly properties make it ideal for use as a diagnostic tool or a target for therapeutic intervention.

CDC190 has been shown to be involved in various signaling pathways that are related to the development and progression of neurodegenerative diseases. For example, studies have shown that CDC190 is involved in the regulation of neurotransmitter release and that it plays a role in synaptic plasticity.

Conclusion

In conclusion, CDC190 is a protein that has been identified as a potential drug target and biomarker for neurodegenerative diseases. Its unique structure and self-assembly properties make it an attractive target for therapeutic intervention, and its potential as a biomarker for neurodegenerative diseases makes it an important tool for diagnostic research. Further studies are needed to fully understand the role of CDC190 in neurodegenerative diseases and to develop effective treatments.

Protein Name: Coiled-coil Domain Containing 190

The "CCDC190 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC190 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets